Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism

Progress in Neurobiology

Volumn 76, Issue 2, 2005, Pages 77-98

  Block, Michelle L ^a   Hong, Jau Shyong ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; INTERLEUKIN 1; NEUROMELANIN; NITROGEN OXIDE; PARAQUAT; PROSTAGLANDIN E2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROTENONE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; CELL ACTIVATION; CELL CYCLE; CENTRAL NERVOUS SYSTEM; DEMENTIA; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROGLIA; MICROGLIA; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PARTICULATE MATTER; PRIORITY JOURNAL; REVIEW;

AMYLOID BETA-PROTEIN; ANIMALS; DOPAMINE; HUMANS; INFLAMMATION; MICROGLIA; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; TOXINS, BIOLOGICAL;

EID: 24144453087     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2005.06.004     Document Type: Review

References (216)

1. F. Aloisi The role of microglia and astrocytes in CNS immune surveillance and immunopathology Adv. Exp. Med. Biol. 468 1999 123 133
2. B.M. Babior Phagocytes and oxidative stress Am. J. Med. 109 2000 33 44
3. M. Bahat-Stroomza, Y. Gilgun-Sherki, D. Offen, H. Panet, A. Saada, N. Krool-Galron, A. Barzilai, D. Atlas, and E. Melamed A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease Eur. J. Neurosci. 21 2005 637 646
4. M.E. Bamberger, M.E. Harris, D.R. McDonald, J. Husemann, and G.E. Landreth A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation J. Neurosci. 23 2003 2665 2674
5. R.B. Banati, J. Gehrmann, M. Kellner, and F. Holsboer Antibodies against microglia/brain macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia Clin. Neuropathol. 14 1995 197 200
6. R.B. Banati, J. Newcombe, R.N. Gunn, A. Cagnin, F. Turkheimer, F. Heppner, G. Price, F. Wegner, G. Giovannoni, D.H. Miller, G.D. Perkin, T. Smith, A.K. Hewson, G. Bydder, G.W. Kreutzberg, T. Jones, M.L. Cuzner, and R. Myers The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity Brain 123 Pt 11 2000 2321 2337
7. A. Barbeau, L. Dallaire, N.T. Buu, J. Poirier, and E. Rucinska Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens Life Sci. 37 1985 1529 1538
8. Y.A. Barde Trophic factors and neuronal survival Neuron 2 1989 1525 1534
9. K.D. Barron The microglial cell. A historical review J. Neurol. Sci. 134 Suppl. 1995 57 68
10. M. Basso, S. Giraudo, D. Corpillo, B. Bergamasco, L. Lopiano, and M. Fasano Proteome analysis of human substantia nigra in Parkinson's disease Proteomics 4 2004 3943 3952
11. C. Bate, R. Veerhuis, P. Eikelenboom, and A. Williams Microglia kill amyloid-beta1-42 damaged neurons by a CD14-dependent process Neuroreport 15 2004 1427 1430
12. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
13. M. Beyer, U. Gimsa, I.Y. Eyupoglu, N.P. Hailer, and R. Nitsch Phagocytosis of neuronal or glial debris by microglial cells: upregulation of MHC class II expression and multinuclear giant cell formation in vitro Glia 31 2000 262 266
14. M.L. Block, X. Wu, Z. Pei, G. Li, T. Wang, L. Qin, B. Wilson, J. Yang, J.S. Hong, and B. Veronesi Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase FASEB J. 18 2004 1618 1620
15. K. Boztug, M.J. Carson, N. Pham-Mitchell, V.C. Asensio, J. DeMartino, and I.L. Campbell Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10 J. Immunol. 169 2002 1505 1515
16. H. Braak, and E. Braak Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder Neurobiol. Aging 15 1994 355 356 (Discussion 379-380)
17. H. Budka The definition of HIV-specific neuropathology Acta Pathol. Jpn. 41 1991 182 191
18. V.P. Calabrese, and M.G. Hadfield Parkinsonism and extraocular motor abnormalities with unusual neuropathological findings Mov. Disord. 6 1991 257 260
19. L. Calderon-Garciduenas, B. Azzarelli, H. Acuna, R. Garcia, T.M. Gambling, N. Osnaya, S. Monroy, MR FD.E.L.T., J.L. Carson, A. Villarreal-Calderon, and B. Rewcastle Air pollution and brain damage Toxicol. Pathol. 30 2002 373 389
20. L. Calderon-Garciduenas, R.R. Maronpot, R. Torres-Jardon, C. Henriquez-Roldan, R. Schoonhoven, H. Acuna-Ayala, A. Villarreal-Calderon, J. Nakamura, R. Fernando, W. Reed, B. Azzarelli, and J.A. Swenberg DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration Toxicol. Pathol. 31 2003 524 538
21. L. Calderon-Garciduenas, W. Reed, R.R. Maronpot, C. Henriquez-Roldan, R. Delgado-Chavez, A. Calderon-Garciduenas, I. Dragustinovis, M. Franco-Lira, M. Aragon-Flores, A.C. Solt, M. Altenburg, R. Torres-Jardon, and J.A. Swenberg Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution Toxicol. Pathol. 32 2004 650 658
22. A. Campbell, M. Oldham, A. Becaria, S.C. Bondy, D. Meacher, C. Sioutas, C. Misra, L.B. Mendez, and M. Kleinman Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain Neurotoxicology 26 2005 133 140
23. E. Caron, and A. Hall Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases Science 282 1998 1717 1721
24. P.M. Carvey, Q. Chang, J.W. Lipton, and Z. Ling Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease Front Biosci. 8 2003 s826 s837
25. L. Chakrabarti, M. Hurtrel, M.A. Maire, R. Vazeux, D. Dormont, L. Montagnier, and B. Hurtrel Early viral replication in the brain of SIV-infected rhesus monkeys Am. J. Pathol. 139 1991 1273 1280
26. R.C. Chang, P. Hudson, B. Wilson, L. Haddon, and J.S. Hong Influence of neurons on lipopolysaccharide-stimulated production of nitric oxide and tumor necrosis factor-alpha by cultured glia Brain Res. 853 2000 236 244
27. R.C. Chang, C. Rota, R.E. Glover, R.P. Mason, and J.S. Hong A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: a study by electron paramagnetic resonance spectroscopy Brain Res. 854 2000 224 229
28. C.C. Chao, S. Hu, T.W. Molitor, E.G. Shaskan, and P.K. Peterson Activated microglia mediate neuronal cell injury via a nitric oxide mechanism J. Immunol. 149 1992 2736 2741
29. C.A. Colton, and D.L. Gilbert Production of superoxide anions by a CNS macrophage, the microglia FEBS Lett. 223 1987 284 288
30. S. Columba-Cabezas, B. Serafini, E. Ambrosini, M. Sanchez, G. Penna, L. Adorini, and F. Aloisi Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation J. Neuroimmunol. 130 2002 10 21
31. C.K. Combs, D.E. Johnson, J.C. Karlo, S.B. Cannady, and G.E. Landreth Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists J. Neurosci. 20 2000 558 567
32. P.N. Cooper, C.A. Siddons, and D.M. Mann Patterns of glial cell activity in fronto-temporal dementia (lobar atrophy) Neuropathol. Appl. Neurobiol. 22 1996 17 22
33. M.A. Cosenza, M.L. Zhao, Q. Si, and S.C. Lee Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis Brain Pathol. 12 2002 442 455
34. J.M. Craft, D.M. Watterson, S.A. Frautschy, and L.J. Van Eldik Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo Neurobiol. Aging 25 2004 1283 1292
35. R.J. D'Amato, Z.P. Lipman, and S.H. Snyder Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin Science 231 1986 987 989
36. -/- knock-out mice J. Neurosci. 23 2003 8532 8538
37. T.G. D'Aversa, K.O. Yu, and J.W. Berman Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat J. Neurovirol. 10 2004 86 97
38. J.B. Davis, H.F. McMurray, and D. Schubert The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes Biochem. Biophys. Res. Commun. 189 1992 1096 1100
39. P. del Rio-Hortega Cytology and cellular pathology of the nervous system 1932 Penfeild Wed New York
40. Dheen, S.T., Jun, Y., Yan, Z., Tay, S.S., Ang Ling, E., 2004. Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia.
41. R.C. Dodel, H. Hampel, and Y. Du Immunotherapy for Alzheimer's disease Lancet Neurol. 2 2003 215 220
42. R.C. Duvoisin, J. Lobo-Antunes, and M.D. Yahr Response of patients with postencephalitic Parkinsonism to levodopa J. Neurol. Neurosurg. Psychiatry 35 1972 487 495
43. R.C. Duvoisin, M.D. Yahr, M.D. Schweitzer, and H.H. Merritt Parkinsonism before and since the epidemic of encephalitis lethargica Arch. Neurol. 30 1963 232 236
44. P. Eikelenboom, C. Bate, W.A. Van Gool, J.J. Hoozemans, J.M. Rozemuller, R. Veerhuis, and A. Williams Neuroinflammation in Alzheimer's disease and prion disease Glia 40 2002 232 239
45. M.M. El Kossi, and M.M. Zakhary Oxidative stress in the context of acute cerebrovascular stroke Stroke 31 2000 1889 1892
46. A. Elbaz, C. Levecque, J. Clavel, J.S. Vidal, F. Richard, P. Amouyel, A. Alperovitch, M.C. Chartier-Harlin, and C. Tzourio CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease Ann. Neurol. 55 2004 430 434
47. S. Elkabes, E.M. DiCicco-Bloom, and I.B. Black Brain microglia/ macrophages express neurotrophins that selectively regulate microglial proliferation and function J. Neurosci. 16 1996 2508 2521
48. Z.H. Feng, T.G. Wang, D.D. Li, P. Fung, B.C. Wilson, B. Liu, S.F. Ali, R. Langenbach, and J.S. Hong Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra Neurosci. Lett. 329 2002 354 358
49. G.L. Finch, C.H. Hobbs, L.F. Blair, E.B. Barr, F.F. Hahn, R.J. Jaramillo, J.E. Kubatko, T.H. March, R.K. White, J.R. Krone, M.G. Menache, K.J. Nikula, J.L. Mauderly, J. Van Gerpen, M.D. Merceica, B. Zielinska, L. Stankowski, K. Burling, and S. Howell Effects of subchronic inhalation exposure of rats to emissions from a diesel engine burning soybean oil-derived biodiesel fuel Inhalib. Toxicol. 14 2002 1017 1048
50. H.J. Forman, and M. Torres Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling Am. J. Respir. Crit. Care Med. 166 2002 S4 S8
51. B. Fornstedt, A. Brun, E. Rosengren, and A. Carlsson The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra J. Neural. Transm. Park Dis. Dement Sect. 1 1989 279 295
52. S. Freude, J. Hausmann, M. Hofer, N. Pham-Mitchell, I.L. Campbell, P. Staeheli, and A. Pagenstecher Borna disease virus accelerates inflammation and disease associated with transgenic expression of interleukin-12 in the central nervous system J. Virol. 76 2002 12223 12232
53. W.J. Friedman, L. Larkfors, C. Ayer-LeLievre, T. Ebendal, L. Olson, and H. Persson Regulation of beta-nerve growth factor expression by inflammatory mediators in hippocampal cultures J. Neurosci. Res. 27 1990 374 382
54. R. Furlan, E. Brambilla, F. Sanvito, L. Roccatagliata, S. Olivieri, A. Bergami, S. Pluchino, A. Uccelli, G. Comi, and G. Martino Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice Brain 126 2003 285 291
55. H.M. Gao, J.S. Hong, W. Zhang, and B. Liu Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons J. Neurosci. 22 2002 782 790
56. H.M. Gao, J. Jiang, B. Wilson, W. Zhang, J.S. Hong, and B. Liu Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease J. Neurochem. 81 2002 1285 1297
57. H.M. Gao, B. Liu, and J.S. Hong Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons J. Neurosci. 23 2003 6181 6187
58. H.M. Gao, B. Liu, W. Zhang, and J.S. Hong Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease FASEB J. 2003
59. H.M. Gao, B. Liu, W. Zhang, and J.S. Hong Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease FASEB J. 17 2003 1957 1959
60. G.A. Garden, W. Guo, S. Jayadev, C. Tun, S. Balcaitis, J. Choi, T.J. Montine, T. Moller, and R.S. Morrison HIV associated neurodegeneration requires p53 in neurons and microglia FASEB J. 18 2004 1141 1143
61. D.A. Gayle, Z. Ling, C. Tong, T. Landers, J.W. Lipton, and P.M. Carvey Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide Brain Res. Dev. Brain Res. 133 2002 27 35
62. D. Giulian, L.J. Haverkamp, J.H. Yu, W. Karshin, D. Tom, J. Li, J. Kirkpatrick, L.M. Kuo, and A.E. Roher Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia J. Neurosci. 16 1996 6021 6037
63. M.B. Graeber, W.J. Streit, and G.W. Kreutzberg The microglial cytoskeleton: vimentin is localized within activated cells in situ J. Neurocytol. 17 1988 573 580
64. H. Grant, P.L. Lantos, and C. Parkinson Cerebral damage in paraquat poisoning Histopathology 4 1980 185 195
65. S.P. Green, B. Cairns, J. Rae, C. Errett-Baroncini, J.A. Hongo, R.W. Erickson, and J.T. Curnutte Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation J. Cereb. Blood Flow Metab. 21 2001 374 384
66. J.T. Greenamyre, G. MacKenzie, T.I. Peng, and S.E. Stephans Mitochondrial dysfunction in Parkinson's disease Biochem. Soc. Symp. 66 1999 85 97
67. K.Z. Guyton, M. Gorospe, T.W. Kensler, and N.J. Holbrook Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion Cancer Res. 56 1996 3480 3485
68. K. Gwinn-Hardy Genetics of parkinsonism Mov. Disord. 17 2002 645 656
69. E.D. Hall, J.A. Oostveen, and M.E. Gurney Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS Glia 23 1998 249 256
70. E. Hansson, and L. Ronnback Astrocytes in glutamate neurotransmission FASEB J. 9 1995 343 350
71. K.E. Hill, L.V. Zollinger, H.E. Watt, N.G. Carlson, and J.W. Rose Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage J. Neuroimmunol. 151 2004 171 179
72. E. Hirsch, A.M. Graybiel, and Y.A. Agid Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease Nature 334 1988 345 348
73. B. Holdorff Friedrich Heinrich Lewy (1885-1950) and his work J. Hist. Neurosci. 11 2002 19 28
74. H.K. Hudnell Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies Neurotoxicology 20 1999 379 397
75. Y. Huh, J.W. Jung, C. Park, J.R. Ryu, C.Y. Shin, W.K. Kim, and J.H. Ryu Microglial activation and tyrosine hydroxylase immunoreactivity in the substantia nigral region following transient focal ischemia in rats Neurosci. Lett. 349 2003 63 67
76. S.D. Hurley, S.A. Walter, S.L. Semple-Rowland, and W.J. Streit Cytokine transcripts expressed by microglia in vitro are not expressed by ameboid microglia of the developing rat central nervous system Glia 25 1999 304 309
77. M. Ii, M. Sunamoto, K. Ohnishi, and Y. Ichimori beta-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity Brain Res. 720 1996 93 100
78. A. Iregren Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests Neurotoxicology 20 1999 315 323
79. M. Jeffrey, C.M. Goodsir, M.E. Bruce, P.A. McBride, and C. Farquhar Morphogenesis of amyloid plaques in 87V murine scrapie Neuropathol. Appl. Neurobiol. 20 1994 535 542
80. K.A. Jellinger The pathology of Parkinson's disease Adv. Neurol. 86 2001 55 72
81. P. Jenner Parkinson's disease, pesticides and mitochondrial dysfunction Trends Neurosci. 24 2001 245 247
82. L.K. Jensen, H. Klausen, and C. Elsnab Organic brain damage in garage workers after long-term exposure to diesel exhaust fumes Ugeskr Laeger 151 1989 2255 2258
83. G.H. Jeohn, L.Y. Kong, B. Wilson, P. Hudson, and J.S. Hong Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures J. Neuroimmunol. 85 1998 1 10
84. C.A. Jordan, B.A. Watkins, C. Kufta, and M. Dubois-Dalcq Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent J. Virol. 65 1991 736 742
85. E.J. Kahn MA, G.J. Speight, and J. de Vellis CNTF regulaation of astrogliosis and the activation of microglia in the developing rat central nervous system Brain Res. 685 1995 55 67
86. W.G. Kim, R.P. Mohney, B. Wilson, G.H. Jeohn, B. Liu, and J.S. Hong Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia J. Neurosci. 20 2000 6309 6316
87. Kim, Y.S., Choi, D.H., Block, M.L., Yang, L., Lorenz, S., Shin, D.H., Sugama, S., Browne, S.E., Hong, J.-S., Beal, M.F., Joh, T.H., in review. Matrix metalloproteinase-3 inhibition prevents dopamine neuronal degeneration. Neuroscience.
88. Y.S. Kim, S.S. Kim, J.J. Cho, D.H. Choi, O. Hwang, D.H. Shin, H.S. Chun, M.F. Beal, and T.H. Joh Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia J. Neurosci. 25 2005 3701 3711
89. J. Koenigsknecht, and G. Landreth Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism J. Neurosci. 24 2004 9838 9846
90. L.Y. Kong, B.C. Wilson, M.K. McMillian, G. Bing, P.M. Hudson, and J.S. Hong The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures Cell Immunol. 172 1996 77 83
91. H. Konishi, M. Tanaka, Y. Takemura, H. Matsuzaki, Y. Ono, U. Kikkawa, and Y. Nishizuka Activation of protein kinase C by tyrosine phosphorylation in response to H2O2 Proc. Natl. Acad. Sci. U.S.A. 94 1997 11233 11237
92. J. Kowalski, K. Labuzek, and Z.S. Herman Flupentixol and trifluperidol reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures Pol. J. Pharmacol. 56 2004 563 570
93. S.G. Kremlev, R.L. Roberts, and C. Palmer Differential expression of chemokines and chemokine receptors during microglial activation and inhibition J. Neuroimmunol. 149 2004 1 9
94. G.W. Kreutzberg Microglia: a sensor for pathological events in the CNS Trends Neurosci. 19 1996 312 318
95. K. Kure, K.M. Weidenheim, W.D. Lyman, and D.W. Dickson Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration Acta Neuropathol. (Berl.) 80 1990 393 400
96. I. Kurkowska-Jastrzebska, A. Wronska, M. Kohutnicka, A. Czlonkowski, and A. Czlonkowska MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease Acta Neurobiol. Exp. (Wars) 59 1999 1 8
97. R. Ladeby, M. Wirenfeldt, D. Garcia-Ovejero, C. Fenger, L. Dissing-Olesen, I. Dalmau, and B. Finsen Microglial cell population dynamics in the injured adult central nervous system Brain Res. Brain Res. Rev. 48 2005 196 206
98. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
99. J.W. Langston, L.S. Forno, J. Tetrud, A.G. Reeves, J.A. Kaplan, and D. Karluk Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Ann. Neurol. 46 1999 598 605
100. M.A. Laurenzi, C. Arcuri, R. Rossi, P. Marconi, and V. Bocchini Effects of microenvironment on morphology and function of the microglial cell line BV-2 Neurochem. Res. 26 2001 1209 1216
101. S.C. Lee, W. Liu, D.W. Dickson, C.F. Brosnan, and J.W. Berman Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta J. Immunol. 150 1993 2659 2667
102. Y.B. Lee, J. Satoh, D.G. Walker, and S.U. Kim Interleukin-15 gene expression in human astrocytes and microglia in culture Neuroreport 7 1996 1062 1066
103. S. Lehnardt, L. Massillon, P. Follett, F.E. Jensen, R. Ratan, P.A. Rosenberg, J.J. Volpe, and T. Vartanian Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway Proc. Natl. Acad. Sci. U.S.A. 100 2003 8514 8519
104. Y. Li, and M.A. Trush Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production Biochem. Biophys. Res. Commun. 253 1998 295 299
105. H. Liao, W.Y. Bu, T.H. Wang, S. Ahmed, and Z.C. Xiao Tenascin-R plays a role in neuroprotection via its distinct domains coordinately modulating the microglia function J. Biol. Chem. 2004
106. N.G. Lindquist Accumulation in vitro of 35 S-chlorpromazine in the neuromelanin of human substantia nigra and locus coeruleus Arch Int. Pharmacodyn. Ther. 200 1972 190 195
107. N.G. Lindquist, B.S. Larsson, and A. Lyden-Sokolowski Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin Neurosci. Lett. 93 1988 1 6
108. R.M. Lindsay Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor Neurobiol. Aging 15 1994 249 251
109. Z. Ling, Q.A. Chang, C.W. Tong, S.E. Leurgans, J.W. Lipton, and P.M. Carvey Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally Exp. Neurol. 190 2004 373 383
110. Z. Ling, D.A. Gayle, S.Y. Ma, J.W. Lipton, C.W. Tong, J.S. Hong, and P.M. Carvey In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain Mov. Disord. 17 2002 116 124
111. Z.D. Ling, Q. Chang, J.W. Lipton, C.W. Tong, T.M. Landers, and P.M. Carvey Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain Neuroscience 124 2004 619 628
112. H.H. Liou, R.C. Chen, Y.F. Tsai, W.P. Chen, Y.C. Chang, and M.C. Tsai Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies Toxicol. Appl. Pharmacol. 137 1996 34 41
113. S.A. Lipton, and H.E. Gendelman Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome N. Engl. J. Med. 332 1995 934 940
114. B. Liu, H.M. Gao, and J.S. Hong Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation Environ. Health Perspect 111 2003 1065 1073
115. B. Liu, H.M. Gao, J.Y. Wang, G.H. Jeohn, C.L. Cooper, and J.S. Hong Role of nitric oxide in inflammation-mediated neurodegeneration Ann. N.Y. Acad. Sci. 962 2002 318 331
116. B. Liu, and J.S. Hong Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention J. Pharmacol. Exp. Ther. 304 2003 1 7
117. L. Liu, Y. Li, L.J. Van Eldik, W.S. Griffin, and S.W. Barger S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors J. Neurochem. 92 2005 546 553
118. Q. Liu, M.A. Smith, J. Avila, J. Debernardis, M. Kansal, A. Takeda, X. Zhu, A. Nunomura, K. Honda, P.I. Moreira, C.R. Oliveira, M.S. Santos, S. Shimohama, G. Aliev, J. de la Torre, H.A. Ghanbari, S.L. Siedlak, P.L. Harris, L.M. Sayre, and G. Perry Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations Free Radic. Biol. Med. 38 2005 746 754
119. D.A. Loeffler, A.J. DeMaggio, P.L. Juneau, M.K. Havaich, and P.A. LeWitt Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation Clin. Neuropharmacol. 17 1994 370 379
120. J.Y. Ma, and J.K. Ma The dual effect of the particulate and organic components of diesel exhaust particles on the alteration of pulmonary immune/inflammatory responses and metabolic enzymes J. Environ. Sci. Health Part C: Environ. Carcinog. Ecotoxicol. Rev. 20 2002 117 147
121. C.L. Mack, C.L. Vanderlugt-Castaneda, K.L. Neville, and S.D. Miller Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis J. Neuroimmunol. 144 2003 68 79
122. D.M. Mann Dementia of frontal type and dementias with subcortical gliosis Brain Pathol. 8 1998 325 338
123. Y. Matsumoto, K. Ohmori, and M. Fujiwara Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system J. Neuroimmunol. 37 1992 23 33
124. P.L. McGeer, H. Akiyama, S. Itagaki, and E.G. McGeer Immune system response in Alzheimer's disease Can. J. Neurol. Sci. 16 1989 516 527
125. P.L. McGeer, S. Itagaki, B.E. Boyes, and E.G. McGeer Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1988 1285 1291
126. P.L. McGeer, S. Itagaki, H. Tago, and E.G. McGeer Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR Neurosci. Lett. 79 1987 195 200
127. P.L. McGeer, and E.G. McGeer Anti-inflammatory drugs in the fight against Alzheimer's disease Ann. N.Y. Acad. Sci. 777 1996 213 220
128. P.L. McGeer, C. Schwab, A. Parent, and D. Doudet Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine administration Ann. Neurol. 54 2003 599 604
129. L. Meda, M.A. Cassatella, G.I. Szendrei, L. Otvos Jr., P. Baron, M. Villalba, D. Ferrari, and F. Rossi Activation of microglial cells by beta-amyloid protein and interferon-gamma Nature 374 1995 647 650
130. J. Michaels, R.W. Price, and M.K. Rosenblum Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection and fusion Acta Neuropathol. (Berl.) 76 1988 373 379
131. C.E. Milligan, T.J. Cunningham, and P. Levitt Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain J. Comp. Neurol. 314 1991 125 135
132. K.J. Min, H.K. Pyo, M.S. Yang, K.A. Ji, I. Jou, and E.H. Joe Gangliosides activate microglia via protein kinase C and NADPH oxidase Glia 48 2004 197 206
133. O.M. Mitrasinovic, and G.M. Murphy Microglial overexpression of the M-CSF receptor augments phagocytosis of opsonized Abeta Neurobiol. Aging 24 2003 807 815
134. O.M. Mitrasinovic, V.A. Vincent, D. Simsek, and G.M. Murphy Jr. Macrophage colony stimulating factor promotes phagocytosis by murine microglia Neurosci. Lett. 344 2003 185 188
135. M. Mittelbronn, K. Dietz, H.J. Schluesener, and R. Meyermann Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude Acta Neuropathol. (Berl.) 101 2001 249 255
136. Y. Mizuno, N. Hattori, T. Kitada, H. Matsumine, H. Mori, H. Shimura, S. Kubo, H. Kobayashi, S. Asakawa, S. Minoshima, and N. Shimizu Familial Parkinson's disease. Alpha-synuclein and parkin Adv. Neurol. 86 2001 13 21
137. S.C. Morgan, D.L. Taylor, and J.M. Pocock Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades J. Neurochem. 90 2004 89 101
138. T. Morioka, A.N. Kalehua, and W.J. Streit Characterization of microglial reaction after middle cerebral artery occlusion in rat brain J. Comp. Neurol. 327 1993 123 132
139. D.W. Moss, and T.E. Bates Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function Eur. J. Neurosci. 13 2001 529 538
140. D.G. Munoz, D.W. Dickson, C. Bergeron, I.R. Mackenzie, A. Delacourte, and V. Zhukareva The neuropathology and biochemistry of frontotemporal dementia Ann. Neurol. 54 Suppl. 5 2003 24 S28
141. A. Nagai, E. Nakagawa, K. Hatori, H.B. Choi, J.G. McLarnon, M.A. Lee, and S.U. Kim Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines Neurobiol. Dis. 8 2001 1057 1068
142. W. Oehmichen, and M. Gencic Experimental studies on kinetics and functions of monuclear phagozytes of the central nervous system Acta Neuropathol. Suppl. (Berl.) Suppl. 6 1975 285 290
143. C.W. Olanow, and W.G. Tatton Etiology and pathogenesis of Parkinson's disease Annu. Rev. Neurosci. 22 1999 123 144
144. E.E. Olson, and R.J. McKeon Characterization of cellular and neurological damage following unilateral hypoxia/ischemia J. Neurol. Sci. 227 2004 7 19
145. D.M. Paresce, H. Chung, and F.R. Maxfield Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells J. Biol. Chem. 272 1997 29390 29397
146. S. Pawate, Q. Shen, F. Fan, and N.R. Bhat Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma J. Neurosci. Res. 77 2004 540 551
147. M. Perluigi, H. Fai Poon, K. Hensley, W.M. Pierce, J.B. Klein, V. Calabrese, C. De Marco, and D.A. Butterfield Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-A model of familial amyotrophic lateral sclerosis Free Radic. Biol. Med. 38 2005 960 968
148. N.S. Perry, C. Bollen, E.K. Perry, and C. Ballard Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial Pharmacol. Biochem. Behav. 75 2003 651 659
149. E. Polazzi, T. Gianni, and A. Contestabile Microglial cells protect cerebellar granule neurons from apoptosis: evidence for reciprocal signaling Glia 36 2001 271 280
150. B.K. Popivanova, K. Koike, A.B. Tonchev, Y. Ishida, T. Kondo, S. Ogawa, N. Mukaida, M. Inoue, and T. Yamashima Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion Brain Res. 970 2003 195 204
151. H. Possel, H. Noack, G. Keilhoff, and G. Wolf Life imaging of peroxynitrite in rat microglial and astroglial cells: role of superoxide and antioxidants Glia 38 2002 339 350
152. S. Pradhan, N. Pandey, S. Shashank, R.K. Gupta, and A. Mathur Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis Neurology 53 1999 1781 1786
153. L. Qin, Y. Liu, C. Cooper, B. Liu, B. Wilson, and J.S. Hong Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species J. Neurochem. 83 2002 973 983
154. L. Qin, Y. Liu, T. Wang, S.J. Wei, M.L. Block, B. Wilson, B. Liu, and J.S. Hong NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia J. Biol. Chem. 279 2004 1415 1421
155. A. Rasley, I. Marriott, C.R. Halberstadt, K.L. Bost, and J. Anguita Substance P augments Borrelia burgdorferi-induced prostaglandin E2 production by murine microglia J. Immunol. 172 2004 5707 5713
156. P. Rezaie, G. Trillo-Pazos, J. Greenwood, I.P. Everall, and D.K. Male Motility and ramification of human fetal microglia in culture: an investigation using time-lapse video microscopy and image analysis Exp. Cell Res. 274 2002 68 82
157. J.W. Rose, K.E. Hill, H.E. Watt, and N.G. Carlson Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion J. Neuroimmunol. 149 2004 40 49
158. S. Rotshenker Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease J. Mol. Neurosci. 21 2003 65 72
159. E.V. Ryzhova, P. Crino, L. Shawver, S.V. Westmoreland, A.A. Lackner, and F. Gonzalez-Scarano Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples Virology 297 2002 57 67
160. A.H. Sadek, R. Rauch, and P.E. Schulz Parkinsonism due to manganism in a welder Int. J. Toxicol. 22 2003 393 401
161. C. Sanchez-Moreno, J.F. Dashe, T. Scott, D. Thaler, M.F. Folstein, and A. Martin Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke Stroke 35 2004 163 168
162. A. Sasaki, H. Yamaguchi, A. Ogawa, S. Sugihara, and Y. Nakazato Microglial activation in early stages of amyloid beta protein deposition Acta Neuropathol. (Berl.) 94 1997 316 322
163. J. Savill, C. Gregory, and C. Haslett Cell biology. Eat me or die Science 302 2003 1516 1517
164. M. Sawada, N. Kondo, A. Suzumura, and T. Marunouchi Production of tumor necrosis factor-alpha by microglia and astrocytes in culture Brain Res. 491 1989 394 397
165. D. Schenk Amyloid-beta immunotherapy for Alzheimer's disease: the end of
166. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, Z. Liao, I. Lieberburg, R. Motter, L. Mutter, F. Soriano, G. Shopp, N. Vasquez, C. Vandevert, S. Walker, M. Wogulis, T. Yednock, D. Games, and P. Seubert Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
167. F. Schiller Fritz Lewy and his bodies J. Hist. Neurosci. 9 2000 148 151
168. E. Schofield, C. Kersaitis, C.E. Shepherd, J.J. Kril, and G.M. Halliday Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders Brain 126 2003 827 840
169. L.M. Schonrock, T. Kuhlmann, S. Adler, A. Bitsch, and W. Bruck Identification of glial cell proliferation in early multiple sclerosis lesions Neuropathol. Appl. Neurobiol. 24 1998 320 330
170. R. Schreck, P. Rieber, and P.A. Baeuerle Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 EMBO J. 10 1991 2247 2258
171. K. Senior Dosing in phase II trial of Alzheimer's vaccine suspended Lancet Neurol. 1 2002 3
172. D.R. Seo, K.Y. Kim, and Y.B. Lee Interleukin-10 expression in lipopolysaccharide-activated microglia is mediated by extracellular ATP in an autocrine fashion Neuroreport 15 2004 1157 11561
173. M. Shamoto-Nagai, W. Maruyama, Y. Akao, T. Osawa, F. Tribl, M. Gerlach, F.A. Zucca, L. Zecca, P. Riederer, and M. Naoi Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells J. Neural Transm. 111 2004 1253 1265
174. T.B. Sherer, R. Betarbet, J.H. Kim, and J.T. Greenamyre Selective microglial activation in the rat rotenone model of Parkinson's disease Neurosci. Lett. 341 2003 87 90
175. W.H. Shin, D.Y. Lee, K.W. Park, S.U. Kim, M.S. Yang, E.H. Joe, and B.K. Jin Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo Glia 46 2004 142 152
176. Q. Si, M. Cosenza, M.L. Zhao, H. Goldstein, and S.C. Lee GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia Glia 39 2002 174 183
177. Q. Si, M.L. Zhao, A.C. Morgan, C.F. Brosnan, and S.C. Lee 15-deoxy-Delta12, 14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications J. Immunol. 173 2004 3504 3513
178. S. Sopper, M. Demuth, C. Stahl-Hennig, G. Hunsmann, R. Plesker, C. Coulibaly, S. Czub, M. Ceska, E. Koutsilieri, P. Riederer, R. Brinkmann, M. Katz, and V. ter Meulen The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey Virology 220 1996 320 329
179. K. Sriram, J.M. Matheson, S.A. Benkovic, D.B. Miller, M.I. Luster, and J.P. O'Callaghan Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease FASEB J. 16 2002 1474 1476
180. W.J. Streit, M.B. Graeber, and G.W. Kreutzberg Functional plasticity of microglia: a review Glia 1 1988 301 307
181. W.J. Streit, S.A. Walter, and N.A. Pennell Reactive microgliosis Prog. Neurobiol. 57 1999 563 581
182. K. Suk, S. Yeou Kim, and H. Kim Regulation of IL-18 production by IFN gamma and PGE2 in mouse microglial cells: involvement of NF-kB pathway in the regulatory processes Immunol. Lett. 77 2001 79 85
183. M.T. Tacconi Neuronal death: is there a role for astrocytes? Neurochem. Res. 23 1998 759 765
184. H. Takahashi, and K. Wakabayashi The cellular pathology of Parkinson's disease Neuropathology 21 2001 315 322
185. A. Takeuchi, O. Miyaishi, K. Kiuchi, and K. Isobe Macrophage colony-stimulating factor is expressed in neuron and microglia after focal brain injury J. Neurosci. Res. 65 2001 38 44
186. C.M. Tanner Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies Adv. Neurol. 91 2003 133 142
187. P. Teismann, and B. Ferger Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease Synapse 39 2001 167 174
188. P. Teismann, M. Vila, D.K. Choi, K. Tieu, D.C. Wu, V. Jackson-Lewis, and S. Przedborski COX-2 and neurodegeneration in Parkinson's disease Ann. N.Y. Acad. Sci. 991 2003 272 277
189. M. Thiruchelvam, A. McCormack, E.K. Richfield, R.B. Baggs, A.W. Tank, D.A. Di Monte, and D.A. Cory-Slechta Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype Eur. J. Neurosci. 18 2003 589 600
190. M.J. Trifilo, and T.E. Lane Adenovirus-mediated expression of CXCL10 in the central nervous system results in T-cell recruitment and limited neuropathology J. Neurovirol. 9 2003 315 324
191. M. Tsuda, A. Mizokoshi, Y. Shigemoto-Mogami, S. Koizumi, and K. Inoue Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury Glia 45 2004 89 95
192. G. Twig, S.K. Jung, M.A. Messerli, P.J. Smith, and O.S. Shirihai Real-time detection of reactive oxygen intermediates from single microglial cells Biol. Bull. 201 2001 261 262
193. B. Van Everbroeck, I. Dobbeleir, M. De Waele, E. De Leenheir, U. Lubke, J.J. Martin, and P. Cras Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease Acta Neuropathol. (Berl.) 108 2004 194 200
194. R. Veerhuis, I. Janssen, C.J. De Groot, F.L. Van Muiswinkel, C.E. Hack, and P. Eikelenboom Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor Exp. Neurol. 160 1999 289 299
195. A. Vernadakis Neuron-glia interrelations Int. Rev. Neurobiol. 30 1988 149 224
196. B. Veronesi, C. Haar, L. Lee, and M. Oortgiesen The surface charge of visible particulate matter predicts biological activation in human bronchial epithelial cells Toxicol. Appl. Pharmacol. 178 2002 144 154
197. -/- mice Inhalib. Toxicol. 17 2005 235 241
198. B. Veronesi, G. Wei, J.Q. Zeng, and M. Oortgiesen Electrostatic charge activates inflammatory vanilloid (VR1) receptors Neurotoxicology 24 2003 463 473
199. -/- mice Cell Tissue Res. 212 1980 279 294
200. T. Wang, B. Liu, L. Qin, B. Wilson, and J.S. Hong Protective effect of the SOD/catalase mimetic MnTMPyP on inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuronal-glial cultures J. Neuroimmunol. 147 2004 68 72
201. T. Wang, L. Qin, B. Liu, Y. Liu, B. Wilson, T.E. Eling, R. Langenbach, S. Taniura, and J.S. Hong Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia J. Neurochem. 88 2004 939 947
202. G.L. Wenk Neuropathologic changes in Alzheimer's disease J. Clin. Psychiatry 64 Suppl. 9 2003 7 10
203. T. Wilczok, K. Stepien, A. Dzierzega-Lecznar, A. Zajdel, and A. Wilczok Model neuromelanins as antioxidative agents during lipid peroxidation Neurotox. Res. 1 1999 141 147
204. H. Wilms, P. Rosenstiel, J. Sievers, G. Deuschl, L. Zecca, and R. Lucius Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease FASEB J. 17 2003 500 502
205. D.C. Wu, P. Teismann, K. Tieu, M. Vila, V. Jackson-Lewis, H. Ischiropoulos, and S. Przedborski NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease Proc. Natl. Acad. Sci. U.S.A. 100 2003 6145 6150
206. X. Wu, M.L. Block, W. Zhang, L. Qin, B. Wilson, W. Zhang, B. Veronesi, and J.S. Hong The role of microglia in paraquat-induced dopaminergic neurotoxicity Antioxid. Redox. Signal. 7 2005 654 661
207. Y.P. Wu, and R.L. Proia Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice Proc. Natl. Acad. Sci. U.S.A. 101 2004 8425 8430
208. Q. Yan, J. Zhang, H. Liu, S. Babu-Khan, R. Vassar, A.L. Biere, M. Citron, and G. Landreth Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease J. Neurosci. 23 2003 7504 7509
209. B.A. Yankner Amyloid and Alzheimer's disease - cause or effect? Neurobiol. Aging 10 1989 470 471 (Discussion 477-478)
210. B.A. Yankner, L.K. Duffy, and D.A. Kirschner Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides Science 250 1990 279 282
211. L. Zecca, R. Fariello, P. Riederer, D. Sulzer, A. Gatti, and D. Tampellini The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease FEBS Lett. 510 2002 216 220
212. L. Zecca, R. Pietra, C. Goj, C. Mecacci, D. Radice, and E. Sabbioni Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain J. Neurochem. 62 1994 1097 1101
213. L. Zecca, F.A. Zucca, H. Wilms, and D. Sulzer Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics Trends Neurosci. 26 2003 578 580
214. W. Zhang, T. Wang, Z. Pei, D.S. Miller, X. Wu, M.L. Block, B. Wilson, Y. Zhou, J.S. Hong, and J. Zhang Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease FASEB J. 19 2005 533 542
215. W. Zhang, T. Wang, L. Qin, H.M. Gao, B. Wilson, S.F. Ali, J.S. Hong, and B. Liu Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase FASEB J. 18 2004 589 591
216. M.L. Zhao, Q. Si, and S.C. Lee IL-16 expression in lymphocytes and microglia in HIV-1 encephalitis Neuropathol. Appl. Neurobiol. 30 2004 233 242